Tehran University of Medical Sciences

Science Communicator Platform

Share By
Immunopet: Antibody-Based Pet Imaging in Solid Tumors Publisher



Manafifarid R1 ; Ataeinia B2 ; Ranjbar S3 ; Jamshidi Araghi Z4 ; Moradi MM1 ; Pirich C3 ; Beheshti M3
Authors

Source: Frontiers in Medicine Published:2022


Abstract

Immuno-positron emission tomography (immunoPET) is a molecular imaging modality combining the high sensitivity of PET with the specific targeting ability of monoclonal antibodies. Various radioimmunotracers have been successfully developed to target a broad spectrum of molecules expressed by malignant cells or tumor microenvironments. Only a few are translated into clinical studies and barely into clinical practices. Some drawbacks include slow radioimmunotracer kinetics, high physiologic uptake in lymphoid organs, and heterogeneous activity in tumoral lesions. Measures are taken to overcome the disadvantages, and new tracers are being developed. In this review, we aim to mention the fundamental components of immunoPET imaging, explore the groundbreaking success achieved using this new technique, and review different radioimmunotracers employed in various solid tumors to elaborate on this relatively new imaging modality. Copyright © 2022 Manafi-Farid, Ataeinia, Ranjbar, Jamshidi Araghi, Moradi, Pirich and Beheshti.
Other Related Docs
8. Nanotechnology-Based Theranostic Approaches in Brain Diseases, Theranostics Nanomaterials in Drug Delivery (2024)
9. Monoclonal Antibodies for Cancer Immunotherapy, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
10. Theranostic Advances in Breast Cancer in Nuclear Medicine, International Journal of Molecular Sciences (2021)
12. A Concise Review on Cancer Treatment Methods and Delivery Systems, Journal of Drug Delivery Science and Technology (2019)
18. Antibody Administration for Bone Tissue Engineering: A Systematic Review, Current Stem Cell Research and Therapy (2018)
20. Immunopathology and Immunotherapy for Breast Cancer, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)